188 related articles for article (PubMed ID: 12497584)
21. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
Liu CM; Lo YC; Tai MH; Wu BN; Wu WJ; Chou YH; Chai CY; Huang CH; Chen IJ
Prostate; 2009 May; 69(6):610-23. PubMed ID: 19143029
[TBL] [Abstract][Full Text] [Related]
22. [Pilot study on the mechanisms of growth inhibitory effect of cinobufagin on HeLa cells].
Wang L; Wu J; Li M; Yang XW; Cui JR
Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):717-20. PubMed ID: 16483480
[TBL] [Abstract][Full Text] [Related]
23. Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines.
Yin JQ; Shen JN; Su WW; Wang J; Huang G; Jin S; Guo QC; Zou CY; Li HM; Li FB
Acta Pharmacol Sin; 2007 May; 28(5):712-20. PubMed ID: 17439728
[TBL] [Abstract][Full Text] [Related]
24. Cell cycle arrest and protein kinase modulating effect of bufalin on human leukemia ML1 cells.
Jing Y; Watabe M; Hashimoto S; Nakajo S; Nakaya K
Anticancer Res; 1994; 14(3A):1193-8. PubMed ID: 8074471
[TBL] [Abstract][Full Text] [Related]
25. Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Res Commun Mol Pathol Pharmacol; 2004; 115-116():251-64. PubMed ID: 17564322
[TBL] [Abstract][Full Text] [Related]
26. Expression of Nkx3.1 enhances 17beta-estradiol anti-tumor action in PC3 human prostate cancer cells.
Wang P; Liu B; Luo JD; Zhang ZG; Ma Q; Chen ZD
Asian J Androl; 2007 May; 9(3):353-60. PubMed ID: 17486276
[TBL] [Abstract][Full Text] [Related]
27. E2F1 expression in LNCaP prostate cancer cells deregulates androgen dependent growth, suppresses differentiation, and enhances apoptosis.
Libertini SJ; Tepper CG; Guadalupe M; Lu Y; Asmuth DM; Mudryj M
Prostate; 2006 Jan; 66(1):70-81. PubMed ID: 16114066
[TBL] [Abstract][Full Text] [Related]
28. Induction of apoptosis and cell cycle arrest by a chalcone panduratin A isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145.
Yun JM; Kweon MH; Kwon H; Hwang JK; Mukhtar H
Carcinogenesis; 2006 Jul; 27(7):1454-64. PubMed ID: 16497706
[TBL] [Abstract][Full Text] [Related]
29. Involvement of Tiam1 in apoptosis induced by bufalin in HeLa cells.
Cao-Hong ; Shibayama-Imazu T; Masuda Y; Shinki T; Nakajo S; Nakaya K
Anticancer Res; 2007; 27(1A):245-9. PubMed ID: 17352239
[TBL] [Abstract][Full Text] [Related]
30. Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells.
Gravina GL; Festuccia C; Millimaggi D; Dolo V; Tombolini V; de Vito M; Vicentini C; Bologna M
Prostate; 2008 May; 68(7):793-801. PubMed ID: 18324645
[TBL] [Abstract][Full Text] [Related]
31. Drug interactions between the proteasome inhibitor bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF) alpha, and TNF-related apoptosis-inducing ligand in prostate cancer.
An J; Sun YP; Adams J; Fisher M; Belldegrun A; Rettig MB
Clin Cancer Res; 2003 Oct; 9(12):4537-45. PubMed ID: 14555528
[TBL] [Abstract][Full Text] [Related]
32. Mahanine inhibits growth and induces apoptosis in prostate cancer cells through the deactivation of Akt and activation of caspases.
Sinha S; Pal BC; Jagadeesh S; Banerjee PP; Bandyopadhaya A; Bhattacharya S
Prostate; 2006 Sep; 66(12):1257-65. PubMed ID: 16683271
[TBL] [Abstract][Full Text] [Related]
33. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C
Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503
[TBL] [Abstract][Full Text] [Related]
34. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
35. Human agonistic antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2 induces cytotoxicity and apoptosis in prostate cancer and bladder cancer cells.
Shimada O; Wu X; Jin X; Nouh MA; Fiscella M; Albert V; Matsuda T; Kakehi Y
Urology; 2007 Feb; 69(2):395-401. PubMed ID: 17320696
[TBL] [Abstract][Full Text] [Related]
36. Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells.
Minelli A; Bellezza I; Tucci A; Rambotti MG; Conte C; Culig Z
Prostate; 2009 Apr; 69(5):538-47. PubMed ID: 19107848
[TBL] [Abstract][Full Text] [Related]
37. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
38. Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expression.
Hobisch A; Fiechtl M; Sandahl-Sorensen B; Godoy-Tundidor S; Artner-Dworzak E; Ramoner R; Bartsch G; Culig Z
Prostate; 2004 Jun; 59(4):401-8. PubMed ID: 15065088
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of bufalin derivatives with inhibitory activity against prostate cancer cells.
Yuan XF; Tian HY; Li J; Jin L; Jiang ST; Liu KW; Luo C; Middleton DA; Esmann M; Ye WC; Jiang RW
Nat Prod Res; 2014; 28(11):843-7. PubMed ID: 24484199
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis of human prostate androgen-dependent and -independent carcinoma cells induced by an isopropanolic extract of black cohosh involves degradation of cytokeratin (CK) 18.
Hostanska K; Nisslein T; Freudenstein J; Reichling J; Saller R
Anticancer Res; 2005; 25(1A):139-47. PubMed ID: 15816531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]